FOXC2/ADAM12‐dependent radiosensitivity of head and neck squamous cell carcinoma cells

xlomafota13 shared this article with you from Inoreader FOXC2/ADAM12‐dependent radiosensitivity of head and neck squamous cell carcinoma cells Via Head & Neck Abstract Background Radiotherapy greatly benefits patients with tumors, but not all patients show favorable treatment response. This study investigated the impact of forkhead box protein C2 (FOXC2)-mediated a disintegrin and metalloprotease 12 (ADAM12) on the radiosensitivity of head and neck squamous cell carcinoma (HNSCC). Methods After transfection and ionizing radiation, the biological activities of HNSCC cells were assessed. The relationship between ADAM12 and FOXC2 was verified. A xenograft model was used to evaluate the effect of FOXC2 knockdown on HNSCC growth in the context of radiation therapy. Results FOXC2 and ADAM12 were upregulated in irradiated CAL-27 and HN4 cells. Knockdown of FOXC2 suppressed the malignant behaviors of CAL-27 and HN4 cells and inhibited the growth of transplanted tumors in nude mice. FOXC2 could bind ADAM12 promoter. Overexpression of ADAM12 reversed the promotion of FOXC2 silencing on the radiosensitivity of HNSCC cells. Conclusions FOXC2 regulates the radiosensitivity of HNSCC by targeting ADAM12. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.